Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Apart from its hematopoietic function, erythropoietin (Epo) exerts neuroprotective activity upon reduced oxygenation or ischemia of brain, retina, and spinal cord. To examine whether Epo has an impact on the retrograde degeneration of retinal ganglion cells (RGCs) following optic nerve transection in vivo, we made use of our transgenic mouse line tg21 that constitutively expresses human Epo preferentially in neuronal cells without inducing polycythemia. We show that the tg21 retina expresses human Epo and that RGCs in this mouse line carry the Epo receptor. Upon axotomy, the RGCs of Epo transgenic tg21 mice were protected against degeneration, as compared with wild‐type control animals. Western blot analysis revealed decreased phosphorylation levels of STAT‐5 and reduced expression of Bcl‐X L in RGCs of axotomized tg21 animals, suggesting that the corresponding pathways are not crucial for Epo's neuroprotective activity. Increased phosphorylation levels of ERK‐1/‐2 and Akt, as well as decreased caspase‐3 activity, however, were observed in injured tg21 retinae. Injection of selective inhibitors of ERK‐1/‐2 (PD98059) or Akt (Wortmannin) pathways into the vitreous space revealed that transgenic Epo protected the RGCs by a pathway involving ERK‐1/‐2 but not Akt. In view that axotomy‐induced degeneration of RGC occurs slowly, and considering the earlier data on the safety and efficacy of Epo in human stroke patients, we predict the clinical implementation of recombinant human Epo not only in patients with acute ischemic stroke, but also with more delayed degenerative neurological diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased phosphorylation levels of ERK1/-2 and Akt, as well as a decreased caspase-3 activity, however, were observed in injured mouse retinae following optic nerve transection in vivo”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [106]
In the citing paper
“but they were described to confer protection against degeneration [ 106 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [106]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 29 · Cited by 134
Research works printed but not linked: 1
- 10.1097/01.WCB.0000050061.57184.AE · doi:10.1097/01.wcb.0000050061.57184.ae · Paper page
Metadata
- Authors
- Kilic, Ü., Kilic, E., Soliz, J., Bassetti, C. L., Gassmann, M., & Hermann, D. M.
- Affiliations
- Department of Neurology University Hospital Zurich (USZ)
- University of Zurich (CH)
- University Hospital Zurich (CH)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-11-19
- Volume
- 19
- Issue
- 2
- Pages
- 1-14
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2133134763
- Cited by
- 134
- References
- 29
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 5 · 2013: 3 · 2012: 5
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Northern Cancer Care and Research Society
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3200B0-100790/1, 3100A0-1002/4)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- erythropoietin, retinal ganglion cells, axotomy, optic nerve transection, neuroprotection, ERK signaling, Akt signaling, caspase-3, Bcl-xL, STAT5, EPO receptor, transgenic mice, PD98059, wortmannin, optic neuropathy
- MeSH terms
- Animals, DNA-Binding Proteins, Enzyme Activation, Erythropoietin, Humans, Male, Mice, Transgenic, Milk Proteins, Nerve Degeneration, Optic Nerve, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Retina, Retinal Ganglion Cells, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Receptors, Erythropoietin, Neuroprotective Agents, Proto-Oncogene Proteins c-bcl-2, Axotomy, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase 1, Caspases, JNK Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, STAT5 Transcription Factor, bcl-X Protein, Proto-Oncogene Proteins c-akt, Mice, Caspase 3, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. https://app.cochat.ai/papers/10.1096/fj.04-2493fje
- The paper
- Kilic, Ü., Kilic, E., Soliz, J., Bassetti, C. L., Gassmann, M., & Hermann, D. M. (2005). Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. The FASEB Journal. https://doi.org/10.1096/fj.04-2493fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.